About The frankel group
The Frankel Group: Delivering Exceptional Life Sciences Consulting Services
The Frankel Group is a leading life sciences consulting firm that specializes in providing innovative solutions to pharmaceutical, medical device, and biotechnology companies. With a team of experienced professionals who possess deep industry knowledge and expertise, The Frankel Group helps its clients navigate the complex challenges of the life sciences sector.
Founded in 2003 by Dr. David Frankel, The Frankel Group has established itself as a trusted partner for companies seeking to improve their operations and achieve better outcomes for patients. Over the years, the firm has built an impressive track record of success by delivering customized solutions that are tailored to each client's unique needs.
At The Frankel Group, we understand that every company faces its own set of challenges when it comes to developing and commercializing new products. That's why we take a collaborative approach to our work, working closely with our clients to gain a deep understanding of their business objectives and develop strategies that align with those goals.
Our team consists of experts in areas such as regulatory affairs, clinical development, market access strategy, health economics and outcomes research (HEOR), medical affairs, commercialization strategy and more. We leverage this expertise to help our clients overcome obstacles at every stage of the product lifecycle – from early-stage development through post-launch activities.
One area where The Frankel Group excels is in helping companies navigate complex regulatory environments around the world. Our regulatory affairs experts have extensive experience working with agencies such as FDA (US Food & Drug Administration), EMA (European Medicines Agency), PMDA (Pharmaceuticals & Medical Devices Agency) Japan etc., ensuring compliance with local regulations while also maximizing opportunities for success.
Another key area where we add value is in helping companies develop effective market access strategies that enable them to bring their products to market quickly while also achieving optimal pricing and reimbursement levels. Our HEOR experts conduct rigorous analyses using advanced modeling techniques which help us identify key drivers behind payer decision-making processes across different markets globally.
In addition to these core services areas mentioned above ,we also offer specialized services like Medical Affairs support including KOL engagement programs , Scientific Communications support including publication planning & execution , Commercialization Strategy support including Launch Excellence programs etc., all designed specifically for life sciences organizations looking for comprehensive solutions under one roof .
At The Frankel Group we pride ourselves on delivering exceptional results for our clients .We believe this is possible because we are passionate about what we do - helping life sciences organizations succeed -and because we have built strong relationships based on trust over time . We look forward continuing this journey together!